PURA VIDA INVESTMENTS, LLC - Q1 2022 holdings

$3.08 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 226 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .

 Value Shares↓ Weighting
ACIU ExitAC IMMUNE SA$0-33,997
-100.0%
-0.01%
ARDX ExitARDELYX INC$0-229,916
-100.0%
-0.01%
CBIO ExitCATALYST BIOSCIENCES INC$0-356,804
-100.0%
-0.01%
IPHA ExitINNATE PHARMA S Asponsored ads$0-79,896
-100.0%
-0.01%
CTMX ExitCYTOMX THERAPEUTICS INC$0-96,905
-100.0%
-0.02%
ExitCORTEXYME INCput$0-38,800
-100.0%
-0.02%
LOGC ExitLOGICBIO THERAPEUTICS INC$0-230,121
-100.0%
-0.02%
INSM ExitINSMED INC$0-19,713
-100.0%
-0.02%
AVEO ExitAVEO PHARMACEUTICALS INC$0-123,416
-100.0%
-0.02%
PSTX ExitPOSEIDA THERAPEUTICS INC$0-89,886
-100.0%
-0.02%
ExitCOMPASS PATHWAYS PLCcall$0-28,300
-100.0%
-0.02%
ExitDECIPHERA PHARMACEUTICALS INput$0-65,700
-100.0%
-0.02%
ExitCARIBOU BIOSCIENCES INC$0-41,932
-100.0%
-0.02%
AMRN ExitAMARIN CORP PLCspons adr new$0-197,130
-100.0%
-0.02%
IMCR ExitIMMUNOCORE HLDGS PLCads$0-19,071
-100.0%
-0.02%
ACRS ExitACLARIS THERAPEUTICS INC$0-48,266
-100.0%
-0.02%
ENVB ExitENVERIC BIOSCIENCES INC$0-742,046
-100.0%
-0.02%
MRTX ExitMIRATI THERAPEUTICS INC$0-4,872
-100.0%
-0.03%
NGM ExitNGM BIOPHARMACEUTICALS INC$0-42,069
-100.0%
-0.03%
OYST ExitOYSTER PT PHARMA INC$0-41,130
-100.0%
-0.03%
SPKBU ExitSILVER SPIKE ACQUISITN CORPunit 02/26/2026$0-77,505
-100.0%
-0.03%
ExitKRYSTAL BIOTECH INCput$0-12,100
-100.0%
-0.03%
RDUS ExitRADIUS HEALTH INC$0-124,607
-100.0%
-0.03%
OLMA ExitOLEMA PHARMACEUTICALS INC$0-93,330
-100.0%
-0.03%
VIR ExitVIR BIOTECHNOLOGY INC$0-21,685
-100.0%
-0.03%
ExitARYA SCIENCES ACQUISITN CORP$0-98,980
-100.0%
-0.04%
ExitDECIPHERA PHARMACEUTICALS INcall$0-98,200
-100.0%
-0.04%
KOD ExitKODIAK SCIENCES INC$0-12,115
-100.0%
-0.04%
CCXI ExitCHEMOCENTRYX INC$0-28,118
-100.0%
-0.04%
OMIC ExitSINGULAR GENOMICS SYSTEMS IN$0-90,551
-100.0%
-0.04%
ExitROIVANT SCIENCES LTD$0-104,413
-100.0%
-0.04%
BEAM ExitBEAM THERAPEUTICS INC$0-13,978
-100.0%
-0.04%
ExitBELLUS HEALTH INC NEWput$0-141,700
-100.0%
-0.04%
ABGI ExitABG ACQUISITION CORP I$0-116,070
-100.0%
-0.04%
DCPH ExitDECIPHERA PHARMACEUTICALS IN$0-114,945
-100.0%
-0.04%
ACAD ExitACADIA PHARMACEUTICALS INC$0-50,000
-100.0%
-0.04%
APRE ExitAPREA THERAPEUTICS INC$0-433,859
-100.0%
-0.04%
KURA ExitKURA ONCOLOGY INC$0-89,612
-100.0%
-0.04%
ExitLUCIRA HEALTH INCcall$0-147,800
-100.0%
-0.05%
IONS ExitIONIS PHARMACEUTICALS INC$0-48,544
-100.0%
-0.05%
SRRA ExitSIERRA ONCOLOGY INC$0-71,320
-100.0%
-0.06%
PMGMU ExitPRIVETERRA ACQUISITION CORPunit 99/99/9999$0-157,759
-100.0%
-0.06%
ExitSTRYVE FOODS INC$0-437,551
-100.0%
-0.06%
IMGN ExitIMMUNOGEN INC$0-249,283
-100.0%
-0.07%
MRK ExitMERCK & CO INC$0-24,246
-100.0%
-0.07%
ARNA ExitARENA PHARMACEUTICALS INC$0-24,361
-100.0%
-0.08%
ExitADAPTHEALTH CORPput$0-98,600
-100.0%
-0.09%
ExitIMMUNOGEN INCcall$0-325,000
-100.0%
-0.09%
ExitKODIAK SCIENCES INCput$0-29,100
-100.0%
-0.09%
BNTX ExitBIONTECH SEsponsored ads$0-9,857
-100.0%
-0.09%
ExitBAUSCH HEALTH COS INCcall$0-98,600
-100.0%
-0.10%
ExitFATE THERAPEUTICS INCput$0-48,500
-100.0%
-0.10%
ExitRAPID MICRO BIOSYSTEMS INC$0-276,871
-100.0%
-0.11%
ExitORGANOGENESIS HLDGS INCput$0-345,000
-100.0%
-0.12%
ExitAXONICS INCput$0-59,100
-100.0%
-0.12%
ExitIMMUNOGEN INCput$0-484,600
-100.0%
-0.13%
INCY ExitINCYTE CORP$0-49,278
-100.0%
-0.13%
NKTR ExitNEKTAR THERAPEUTICSput$0-283,576
-100.0%
-0.14%
ExitPROCEPT BIOROBOTICS CORP$0-155,214
-100.0%
-0.14%
ExitADAPTIVE BIOTECHNOLOGIES CORcall$0-161,800
-100.0%
-0.16%
ExitMERCK & CO INCcall$0-62,300
-100.0%
-0.17%
RACB ExitRESEARCH ALLIANCE CORP II$0-503,955
-100.0%
-0.18%
ExitNANOSTRING TECHNOLOGIES INCcall$0-118,600
-100.0%
-0.18%
ARYD ExitARYA SCIENCES ACQU CORP IVcl a$0-510,507
-100.0%
-0.18%
ExitETF SER SOLUTIONSput$0-246,400
-100.0%
-0.19%
ExitHOLOGIC INCput$0-75,000
-100.0%
-0.21%
ExitMODERNA INCput$0-23,200
-100.0%
-0.21%
DNAY ExitCODEX DNA INC$0-572,299
-100.0%
-0.22%
PACB ExitPACIFIC BIOSCIENCES CALIF IN$0-330,033
-100.0%
-0.24%
ExitSIGNIFY HEALTH INCput$0-496,700
-100.0%
-0.26%
ExitINTUITIVE SURGICAL INCput$0-20,000
-100.0%
-0.26%
ExitOMEGA HEALTHCARE INVS INCput$0-246,400
-100.0%
-0.26%
ExitOAK STR HEALTH INCput$0-231,600
-100.0%
-0.28%
ExitDELTA AIR LINES INC DELput$0-197,100
-100.0%
-0.28%
ExitTELEFLEX INCORPORATEDput$0-25,800
-100.0%
-0.31%
ExitIDEXX LABS INCput$0-13,100
-100.0%
-0.31%
PFE ExitPFIZER INC$0-152,273
-100.0%
-0.33%
ExitARENA PHARMACEUTICALS INCput$0-97,100
-100.0%
-0.33%
ExitALCON AGput$0-108,100
-100.0%
-0.34%
ExitDANAHER CORPORATIONput$0-30,000
-100.0%
-0.36%
ExitNEOGENOMICS INCput$0-295,700
-100.0%
-0.36%
ExitNUVASIVE INCput$0-216,900
-100.0%
-0.41%
ExitOLAPLEX HLDGS INC$0-399,906
-100.0%
-0.42%
ExitAMYRIS INCcall$0-2,200,000
-100.0%
-0.43%
QTRX ExitQUANTERIX CORP$0-292,877
-100.0%
-0.45%
ExitSOUTHWEST AIRLS COput$0-295,700
-100.0%
-0.46%
ExitPERKINELMER INCput$0-69,600
-100.0%
-0.51%
DXCM ExitDEXCOM INC$0-26,312
-100.0%
-0.51%
SKIN ExitTHE BEAUTY HEALTH COMPANY$0-596,981
-100.0%
-0.52%
ExitCOOPER COS INCput$0-39,500
-100.0%
-0.60%
ExitAMN HEALTHCARE SVCS INCcall$0-150,000
-100.0%
-0.66%
ExitVERTEX PHARMACEUTICALS INCcall$0-97,000
-100.0%
-0.77%
NTRA ExitNATERA INC$0-235,199
-100.0%
-0.80%
ExitDEXCOM INCput$0-43,300
-100.0%
-0.84%
ExitARENA PHARMACEUTICALS INCcall$0-291,100
-100.0%
-0.98%
ExitSELECT SECTOR SPDR TRput$0-400,000
-100.0%
-2.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ICU MED INC26Q2 20234.2%
NANOSTRING TECHNOLOGIES INC26Q2 20233.3%
VIEWRAY INC25Q2 20233.2%
LIVANOVA PLC23Q3 20233.8%
ALEXION PHARMACEUTICALS INC23Q1 20214.3%
INSPIRE MED SYS INC22Q3 20233.7%
BOSTON SCIENTIFIC CORP22Q3 20224.8%
INVACARE CORP22Q3 20212.8%
ESTABLISHMENT LABS HLDGS INC21Q3 20235.0%
INTERSECT ENT INC21Q2 20212.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
PURA VIDA INVESTMENTS, LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Stryve Foods Holdings, LLCApril 19, 20231,470,6495.6%
ICAD INCMarch 15, 20231,277,2145.0%
ESTABLISHMENT LABS HOLDINGS INC.February 14, 20231,002,7674.1%
Pulmonx CorpFebruary 14, 20231,216,2583.2%
Quotient LtdSold outFebruary 14, 202300.0%
Universe Pharmaceuticals INCSold outFebruary 14, 202300.0%
MedMen Enterprises, Inc.April 29, 2022139,755,07221.4%
INVACARE CORPSold outFebruary 14, 202200.0%
MedAvail Holdings, Inc.February 14, 2022714,1202.2%
TELA Bio, Inc.February 14, 2022564,1203.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2024-02-13
SC 13D/A2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

Compare quarters

Export PURA VIDA INVESTMENTS, LLC's holdings